Hsbc Holdings PLC boosted its holdings in Davita Inc (NYSE:DVA) by 4.4% in the third quarter, HoldingsChannel reports. The firm owned 128,642 shares of the company’s stock after purchasing an additional 5,409 shares during the period. Hsbc Holdings PLC’s holdings in Davita were worth $9,215,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. California Public Employees Retirement System boosted its position in shares of Davita by 8.6% during the second quarter. California Public Employees Retirement System now owns 571,830 shares of the company’s stock valued at $39,708,000 after buying an additional 45,102 shares during the last quarter. Hikari Tsushin Inc. boosted its position in shares of Davita by 10.5% during the second quarter. Hikari Tsushin Inc. now owns 74,410 shares of the company’s stock valued at $5,624,000 after buying an additional 7,050 shares during the last quarter. Oppenheimer Asset Management Inc. purchased a new position in shares of Davita during the second quarter valued at approximately $3,421,000. Tibra Equities Europe Ltd purchased a new position in shares of Davita during the second quarter valued at approximately $1,627,000. Finally, Janus Henderson Group PLC boosted its position in shares of Davita by 3.0% during the second quarter. Janus Henderson Group PLC now owns 1,284,092 shares of the company’s stock valued at $89,168,000 after buying an additional 37,362 shares during the last quarter. Institutional investors and hedge funds own 85.76% of the company’s stock.

Shares of Davita stock opened at $64.07 on Thursday. The firm has a market cap of $10.64 billion, a P/E ratio of 19.30, a price-to-earnings-growth ratio of 0.85 and a beta of 1.07. Davita Inc has a 12 month low of $58.68 and a 12 month high of $80.71. The company has a debt-to-equity ratio of 2.09, a quick ratio of 1.82 and a current ratio of 1.84.

Davita (NYSE:DVA) last released its quarterly earnings data on Wednesday, November 7th. The company reported $0.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.33). Davita had a net margin of 5.39% and a return on equity of 13.87%. The company had revenue of $2.85 billion for the quarter, compared to the consensus estimate of $2.93 billion. During the same quarter in the previous year, the firm posted $0.81 earnings per share. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. Research analysts anticipate that Davita Inc will post 3.56 EPS for the current year.

Several brokerages recently issued reports on DVA. Zacks Investment Research cut Davita from a “hold” rating to a “sell” rating in a research report on Tuesday, November 13th. Raymond James lowered Davita from an “outperform” rating to a “market perform” rating and set a $63.44 price target on the stock. in a report on Sunday. ValuEngine upgraded Davita from a “hold” rating to a “buy” rating in a report on Tuesday, October 9th. UBS Group started coverage on Davita in a report on Thursday, November 15th. They set a “sell” rating and a $64.00 price target on the stock. Finally, Royal Bank of Canada lifted their price target on Davita from $70.00 to $78.00 and gave the stock a “sector perform” rating in a report on Thursday, November 8th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $80.16.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.watchlistnews.com/davita-inc-dva-shares-bought-by-hsbc-holdings-plc/2664568.html.

Davita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Further Reading: What is an investor looking for in an SEC filing?

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.